The Quiet Revolution: How Sound Waves Are Rewriting the Future of Seizure Control

The Healing Frontier: Yzi Labs Dives Headfirst into Regenerative Medicine's Bold Promise

The Gene Therapy Dream Interrupted: UniQure Investors Face an Unsettling Inquiry

A Glimmer of Hope: Eli Lilly's Bold Leap into Gene Therapy for Blinding Eye Diseases

The End of the Needle? How Gene Therapy Could Turn Your Body into a GLP-1 Factory

A Single Shot, a Lifetime of Hope? The Gene Therapy Battling Bad Cholesterol

The Pulse of Progress: Why Healthcare Stocks Are Sparking Investor Interest Right Now

A Glimmer of Hope: Tenaya Therapeutics Takes on Hypertrophic Cardiomyopathy with Bold New Gene Therapy

The CRISPR Revolution: A One-Time Fix for a Lifelong Problem? Unpacking the Future of Cholesterol Treatment

Krystal Biotech's Ascendant Star: Why William Blair Is Eyeing a Future of Sky-High Earnings

The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets

A New Dawn in India's Cancer Fight: How Indigenous Gene Therapy is Rewriting the Rules of Hope

The Dawn of a New Era: India's Own Cancer Revolution Takes Hold

The Price of Hope: How Nexcar19 is Rewriting the Rules of Cancer Gene Therapy

A Whisper of Hope for the Heart: Tenaya's Gene Therapy Unveils Promising Data

The Heart of the Matter: A Gene Therapy's Bold Bid Against a Silent Killer

The High Stakes Game: Sarepta, Duchenne, and the Edge of Hope

Beyond the Headlines: Six Wonders of Science You Absolutely Need to Know About

A Sudden Chill for Intellia: FDA Hits Pause on Groundbreaking Gene Therapy Trial

The Million-Dollar Question: Can We Really Afford Tomorrow's Cures?

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

The Silent Rebels of Our DNA: When 'Broken' Genes Actually Fight Back

The Whisper Becomes a Roar: Why Novartis Needs Avidity’s RNA Revolution, Now More Than Ever

The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic

Beyond the Horizon: Manipal's Groundbreaking Conclave Illuminates Cell Therapy's Potential

The Quiet Revolution: Unpacking the Billions Behind Biotech's Essential Cell Banks

Lilly's Bold Bet: A Second Chance for a Troubled Gene Therapy in Retinal Disease

Freya's Fight and the Miracle of Gene Therapy: A New Dawn for MLD Patients

Taysha Gene Therapies Stock Takes a Dive: Unpacking the Impact of Their Latest Public Offering

The Dawn of Precision Medicine: Drugs Delivered by an Army of Microscopic Droplets

Unlocking Precision: How DNA Nanorobots Are Revolutionizing Cancer Therapy

FDA Grants Priority Review to Rocket Pharma's Groundbreaking Gene Therapy for Rare LAD-I

Revolutionizing Biopharma: Waters Unveils Breakthrough Charge Detection Mass Spectrometry for Next-Gen Therapies

The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs

A New Chapter: Peter Marks, Former FDA Vaccine Czar, Lands at Eli Lilly

Unlocking the Future of Medicine: Cell Culture Market Set to Soar to $93.49 Billion by 2032

Soaring to New Heights: The Cell Culture Market Set to Achieve a Staggering $93.49 Billion by 2032

A Beacon of Hope: Gene Therapy Milestone Honors Jesse Den Haan's Legacy in the Fight Against Duchenne Muscular Dystrophy

Ovid Therapeutics Soars: A Game-Changing Deal with Takeda Propels Stock by 18%